CCL2 and Parkinson disease: At least one study reported increased MCP-1 levels in cerebrospinal fluid of PD patients [35] while another study found no difference compared to healthy controls but suggested that the levels of MCP-1 might correlate with disease progression and motor dysfunction [36].